In men, samples that were negative for anti-CCP3 and RF were a median of 5.41 years from a diagnosis of RA compared to samples that were triple positive for anti-CCP3, RF-IgA and RF-IgM that were a median of 1.12 years prior to a diagnosis of RA. This evidence concerns the gene CD79A and rheumatoid arthritis.